Technical Nuances and Outcomes of Telescoping Pipeline Flow Diverters: A Multicenter Study.


Journal

Operative neurosurgery (Hagerstown, Md.)
ISSN: 2332-4260
Titre abrégé: Oper Neurosurg (Hagerstown)
Pays: United States
ID NLM: 101635417

Informations de publication

Date de publication:
01 04 2023
Historique:
received: 20 07 2022
accepted: 22 09 2022
pubmed: 1 2 2023
medline: 21 3 2023
entrez: 31 1 2023
Statut: ppublish

Résumé

"Telescoping" multiple overlapping Pipeline Embolization Devices (PEDs; Medtronic) has increased their utility by allowing for more impermeable coverage and providing the ability to off-set landing zone sites and extend treatment constructs. To consider the technical nuances and challenges of telescoping PEDs for the treatment of intracranial aneurysms. Databases from 3 U.S. academic neurovascular centers were retrospectively queried to identify patients with intracranial aneurysms treated with multiple PED constructs. Data on patient and aneurysm characteristics, as well as outcomes including Raymond-Roy occlusion classification, modified Rankin Scale score, and complications, were gathered. Forty-six patients had 48 intracranial aneurysms treated, including 16 (33%) in whom placement of telescoping PEDs was planned. Fourteen (30%) patients presented with a ruptured aneurysm. Twenty-one aneurysms (44%) were treated with proximal extension, 13 (27%) with distal extension, and 14 (29%) with PED placement inside one another. Thirty (70%) patients had complete aneurysm occlusion at follow-up. Two (4%) patients had to be retreated. Three patients with unruptured and 1 with ruptured aneurysm had a permanent intraprocedural complication. We present descriptive cases illustrating PEDs that were placed inside one another, proximally, distally, and to improve wall apposition because of vessel tortuosity. Our data indicate a higher than expected complication rate that is likely because of the technical complexity of these cases. The case illustrations presented demonstrate the indications and challenging aspects of telescoping PEDs.

Sections du résumé

BACKGROUND
"Telescoping" multiple overlapping Pipeline Embolization Devices (PEDs; Medtronic) has increased their utility by allowing for more impermeable coverage and providing the ability to off-set landing zone sites and extend treatment constructs.
OBJECTIVE
To consider the technical nuances and challenges of telescoping PEDs for the treatment of intracranial aneurysms.
METHODS
Databases from 3 U.S. academic neurovascular centers were retrospectively queried to identify patients with intracranial aneurysms treated with multiple PED constructs. Data on patient and aneurysm characteristics, as well as outcomes including Raymond-Roy occlusion classification, modified Rankin Scale score, and complications, were gathered.
RESULTS
Forty-six patients had 48 intracranial aneurysms treated, including 16 (33%) in whom placement of telescoping PEDs was planned. Fourteen (30%) patients presented with a ruptured aneurysm. Twenty-one aneurysms (44%) were treated with proximal extension, 13 (27%) with distal extension, and 14 (29%) with PED placement inside one another. Thirty (70%) patients had complete aneurysm occlusion at follow-up. Two (4%) patients had to be retreated. Three patients with unruptured and 1 with ruptured aneurysm had a permanent intraprocedural complication. We present descriptive cases illustrating PEDs that were placed inside one another, proximally, distally, and to improve wall apposition because of vessel tortuosity.
CONCLUSION
Our data indicate a higher than expected complication rate that is likely because of the technical complexity of these cases. The case illustrations presented demonstrate the indications and challenging aspects of telescoping PEDs.

Identifiants

pubmed: 36719956
doi: 10.1227/ons.0000000000000552
pii: 01787389-202304000-00018
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e255-e263

Informations de copyright

Copyright © Congress of Neurological Surgeons 2023. All rights reserved.

Références

Shapiro M, Raz E, Becske T, Nelson PK. Building multidevice pipeline constructs of favorable metal coverage: a practical guide. AJNR Am J Neuroradiol. 2014;35(8):1556-1561.
Nelson PK, Lylyk P, Szikora I, Wetzel SG, Wanke I, Fiorella D. The pipeline embolization device for the intracranial treatment of aneurysms trial. AJNR Am J Neuroradiol. 2011;32(1):34-40.
Becske T, Kallmes DF, Saatci I, et al. Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology. 2013;267(3):858-868.
Madaelil TP, Grossberg JA, Howard BM, et al. Aneurysm remnants after flow diversion: clinical and angiographic outcomes. AJNR Am J Neuroradiol. 2019;40(4):694-698.
Waqas M, Vakharia K, Gong AD, et al. One and done? The effect of number of pipeline embolization devices on aneurysm treatment outcomes. Interv Neuroradiol. 2019;26(2):147-155.
Kabbasch C, Mpotsaris A, Behme D, Dorn F, Stavrinou P, Liebig T. Pipeline embolization device for treatment of intracranial aneurysms-the more, the better? A single-center retrospective observational study. J Vasc Interv Neurol. 2016;9(2):14-20.
Roy D, Milot G, Raymond J. Endovascular treatment of unruptured aneurysms. Stroke. 2001;32(9):1998-2004.
Mazur MD, Taussky P, MacDonald JD, Park MS. Rerupture of a blister aneurysm after treatment with a single flow-diverting stent. Neurosurgery. 2016;79(5):E634-E638.
Chalouhi N, Polifka A, Daou B, et al. In-pipeline stenosis: incidence, predictors, and clinical outcomes. Neurosurgery. 2015;77(6):875-879; discussion 879.
Dmytriw AA, Phan K, Moore JM, Pereira VM, Krings T, Thomas AJ. On flow diversion: the changing landscape of intracerebral aneurysm management. AJNR Am J Neuroradiol. 2019;40(4):591-600.

Auteurs

Cordell M Baker (CM)

Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah, USA.

Joshua C Hunsaker (JC)

School of Medicine, University of Utah, Salt Lake City, Utah, USA.

Zach A Folzenlogen (ZA)

Department of Neurosurgery, University of Colorado, Boulder, Colorado, USA.

Glenn L Pride (GL)

Department of Neurosurgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

David E Case (DE)

Department of Neurosurgery, University of Colorado, Boulder, Colorado, USA.

Babu G Welch (BG)

Department of Neurosurgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Jonathan A White (JA)

Department of Neurosurgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Christopher D Roark (CD)

Department of Neurosurgery, University of Colorado, Boulder, Colorado, USA.

Andrew C White (AC)

Department of Neurosurgery, University of Colorado, Boulder, Colorado, USA.
Department of Neurosurgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Joshua Seinfeld (J)

Department of Neurosurgery, University of Colorado, Boulder, Colorado, USA.

John Muse (J)

Department of Neurosurgery, University of Vermont, Burlington, Vermont, USA.

Ramesh Grandhi (R)

Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah, USA.

Philipp Taussky (P)

Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH